IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction

Journal of Immunology

Volumn 178, Issue 1, 2007, Pages 407-415

  Missé, Dorothée ^a   Yssel, Hans ^b   Trabattoni, Daria ^c   Oblet, Christelle ^a   Lo Caputo, Sergio ^d   Mazzotta, Francesco ^d   Pène, Jérome ^b   Gonzalez, Jean Paul ^a   Clerici, Mario ^c   Veas, Francisco ^a,e  

^a Research Institute for Development   (France)

^b INSERM   (France)

^c UNIVERSITY OF MILAN   (Italy)

^d SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^e ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ACUTE PHASE SERUM AMYLOID A; BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CCR5; CYTOKINE; INTERLEUKIN 22; PEROXIREDOXIN; PROTEIN; PROTEOME; SERUM AMYLOID A; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ALLELE; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD CELL; BONE MARROW CELL; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DENDRITIC CELL; DOWN REGULATION; FEMALE; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; INNATE IMMUNITY; MALE; MOLECULAR MODEL; NATURAL KILLER CELL; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SERUM; SEXUALITY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION; VIRUS CELL INTERACTION; WILD TYPE;

EID: 33845925316     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.1.407     Document Type: Article

References (42)

1. Fowke, K. R., N. J. Nagelkerke, J. Kimani, J. N. Simonsen, A. O. Anzala, J. J. Bwayo, K. S. MacDonald, E. N. Ngugi, and F. A. Plummer. 1996. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348: 1347-1351.
2. Rowland-Jones, S. L., and A. McMichael. 1995. Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr. Opin. Immunol. 7: 448-455.
3. + cells. J. Virol. 78: 2277-2287.
4. Paxton, W. A., S. R. Martin, D. Tse, T. R. O'Brien, J. Skurnick, N. L. VanDevanter, N. Padian, J. F. Braun, D. P. Kotler, S. M. Wolinsky, and R. A. Koup. 1996. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat. Med. 2: 412-417.
5. Samson, M., F. Libert, B. J. Doranz, J. Rucker, C. Liesnard, C. M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, et al. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382: 722-725.
6. Clerici, M., A. Sarin, R. L. Coffman, T. A. Wynn, S. P. Blatt, C. W. Hendrix, S. F. Wolf, G. M. Shearer, and P. A. Henkart. 1994. Type I/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc. Natl. Acad. Sci. USA 91: 11811-11815.
7. Hsueh, F. W., C. M. Walker, D. J. Blackbourn, and J. A. Levy. 1994. Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals. Cell. Immunol. 159: 271-279.
8. Mazzoli, S., D. Trabattoni, S. Lo Caputo, S. Piconi, C. Ble, F. Meacci, S. Ruzzante, A. Salvi, F. Semplici, R. Longhi, et al. 1997. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat. Med. 3: 1250-1257.
9. Scott-Algara, D., L. X. Truong, P. Versmisse, A. David, T. T. Luong, N. V. Nguyen, I. Theodorou, F. Barre-Sinoussi, and G. Pancino. 2003. Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J. Immunol. 171: 5663-5667.
10. Kebba, A., P. Kaleebu, S. Rowland, R. Ingram, J. Whitworth, N. Imami, and F. Gotch. 2004. Distinct patterns of peripheral HIV-1-specific interferon-α responses in exposed HIV-1-seronegative individuals. J. Infect. Dis. 189: 1705-1713.
11. Stranford, S. A., J. Skurnick, D. Louria, D. Osmond, S. Y. Chang, J. Sninsky, G. Ferrari, K. Weinhold, C. Lindquist, and J. A. Levy. 1999. Lack of infection in HIV-exposed individuals is associated with a strong CD8+ cell noncytotoxic anti-HIV response. Proc. Natl. Acad. Sci. USA 96: 1030-1035.
12. Trabattoni, D., S. L. Caputo, G. Maffeis, F. Vichi, M. Biasin, P. Pierotti, F. Fasano, M. Saresella, M. Franchira, P. Ferrante, et al. 2004. Human α defensin in HIV-exposed but uninfected individuals. J. Acquir. Immune Defic. Syndr. 35: 455-463.
13. Schenal, M., S. Lo Caputo, F. Fasano, F. Vichi, M. Saresella, P. Pierotti, M. L. Villa, F. Mazzotta, D. Trabattoni, and M. Clerici. 2005. Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients. AIDS 19: 653-661.
14. Bacchetta, R., L. Passerini, E. Gambineri, M. Dai, S. E. Allan, L. Perroni, F. Dagna-Bricarelli, C. Sartirana, S. Matthes-Martin, A. Lawitschka, et al. 2006. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J. Clin. Invest. 116: 1713-1722.
15. Yssel, H., and H. Spits. 2002. Generation and maintenance of T cell lines and clones. In Current Protocols in Immunology, Vol. I. John Wiley & Sons, New York, pp. 1-12.
16. Yssel, H., J. E. De Vries, M. Koken, W. Van Blitterswijk, and H. Spits. 1984. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J. Immunol. Methods 72: 219-227.
17. Scheffold, A., M. Assenmacher, and A. Radbruch. 2002. Phenotyping and separation of leukocyte populations based on affinity labelling. In Immunology of Infection, 2nd Ed. S. Kaufman and D. Kabelitz, eds. Academic Press, London, pp. 23-58.
18. Velculescu, V. E., L. Zhang, B. Vogelstein, and K. W. Kinzler. 1995. Serial analysis of gene expression. Science 270: 484-487.
19. Audic, S., and J. M. Claverie. 1997. The significance of digital gene expression profiles. Genome Res. 1: 986-995.
20. Misse, D., M. Cerutti, N. Noraz, P. Jourdan, J. Favero, G. Devauchelle, H. Yssel, N. Taylor, and F. Veas. 1999. A CD4-independent interaction of human immunodeficiency virus-1 gp120 with CXCR4 induces their cointernalization, cell signaling, and T-cell chemotaxis. Blood 93: 2454-2462.
21. Geiben-Lynn, R., M. Kursar, N. V. Brown, M. M. Addo, H. Shau, J. Lieberman, A. D. Luster, and B. D. Walker. 2003. HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family. J. Biol. Chem. 278: 1569-1574.
22. Rouet, F., D. K. Ekouevi, M. L. Chaix, M. Burgard, A. Inwoley, T. D. Tony, C. Danel, X. Anglaret, V. Leroy, P. Msellati, et al. 2005. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. J. Clin. Microbiol. 43: 2709-2717.
23. Wolk, K., S. Kunz, K. Asadullah, and R. Sabat. 2002. Cutting edge: immune cells as sources and targets of the IL-10 family members? J. Immunol. 168: 5397-5402.
24. Le, Y., M. A. Wetzel, W. Shen, W. Gong, T. J. Rogers, E. E. Henderson, and J. M. Wang. 2001. Desensitization of chemokine receptor CCR5 in dendritic cells at the early stage of differentiation by activation of formyl peptide receptors. Clin. Immunol. 99: 365-372.
25. Ranki, A., S. Mattinen, R. Yarchoan, S. Broder, J. Ghrayeb, J. Lahdevirta, and K. Krohn. 1989. T-cell response towards HIV in infected individuals with and without zidovudine therapy, and in HIV-exposed sexual partners. AIDS 3: 63-69.
26. Shearer, G. M., and M. Clerici. 1996. Protective immunity against HIV infection: has nature done the experiment for us? Immunol. Today 17: 21-24.
27. Jaspan, H. B., H. R. Gaumer, and R. F. Garry. 2003. Expression of granzyme B mRNA is altered in human immunodeficiency virus infected patients. Exp. Mol. Pathol. 74: 13-16.
28. Kim, Y. H., L. Girard, C. P. Giacomini, P. Wang, T. Hernandez-Boussard, R. Tibshirani, J. D. Minna, and J. R. Pollack. 2006. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Oncogene 25: 130-138.
29. + cells in sexually HIV-1-exposed but uninfected individuals. Clin. Immunol. 120: 138-146.
30. Davey, G. M., W. R. Heath, and R. Starr. 2006. SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue Antigens 67: 1-9.
31. Lang, R. 2005. Tuning of macrophage responses by Stat3-inducing cytokines: molecular mechanisms and consequences in infection. Immunobiology 210: 63-76.
32. Wolk, K., S. Kunz, E. Witte, M. Friedrich, K. Asadullah, and R. Sabat. 2004. IL-22 increases the innate immunity of tissues. Immunity 21: 241-254.
33. Dumoutier, L., E. Van Roost, D. Colau, and J. C. Renauld. 2000. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc. Natl. Acad. Sci. USA 97: 10144-10149.
34. Nagalakshmi, M. L., A. Rascle, S. Zurawski, S. Menon, and R. de Waal Malefyt. 2004. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int. Immunopharmacol. 4: 679-691.
35. Uhlar, C. M., C. J. Burgess, P. M. Sharp, and A. S. Whitehead. 1994. Evolution of the serum amyloid A (SAA) protein superfamily. Genomics 19: 228-235.
36. Thorn, C. F., Z. Y. Lu, and A. S. Whitehead. 2004. Regulation of the human acute phase serum amyloid A genes by tumour necrosis factor-α, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines. Scand. J. Immunol. 59: 152-158.
37. Yamada, T., B. Kluve-Beckerman, J. J. Liepnieks, and M. D. Benson. 1994. Fibril formation from recombinant human serum amyloid A. Biochim. Biophys. Acta 1226: 323-329.
38. Le, Y., J. J. Oppenheim, and J. M. Wang. 2001. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev. 12: 91-105.
39. Oppermann, M., M. Mack, A. E. Proudfoot, and H. Olbrich. 1999. Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. J. Biol. Chem. 274: 8875-8885.
40. Kanari, Y., M. Clerici, H. Abe, H. Kawabata, D. Trabattoni, S. L. Caputo, F. Mazzotta, H. Fujisawa, A. Niwa, C. Ishihara, et al. 2005. Genotypes at chromosome 22q12-13 are associated with HIV-1-exposed but uninfected status in Italians. AIDS 19: 1015-1024.
41. Dumoutier, L., E. Van Roost, G. Ameye, L. Michaux, and J. C. Renauld. 2000. IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun. 1: 488-494.
42. Quinones-Mateu, M. E., M. M. Lederman, Z. Feng, B. Chakraborty, J. Weber, H. R. Rangel, M. L. Marotta, M. Mirza, B. Jiang, P. Riser, et al. 2003. Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication. AIDS 17: F39-F48.